Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats

Carcinogenesis

Volumn 22, Issue 12, 2001, Pages 2039-2047

  Thordarson, Gudmundur ^a   Lee, Adrian V ^b   McCarty, Meghan ^a   Van Horn, Katharine ^a   Chu, Oriana ^a   Chou, Yu Chien ^c   Yang, Jason ^c   Guzman, Raphael C ^c   Nandi, Satyabrata ^c   Talamantes, Frank ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CYCLIN D1; CYTOCHROME P450; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; GROWTH HORMONE; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; METHYLNITROSOUREA; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOPROTEIN; PROGESTERONE; PROGESTERONE RECEPTOR; PROLACTIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INVASION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; GENE EXPRESSION; LATENT PERIOD; NONHUMAN; OVARIECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROTO ONCOGENE; RAT; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0035684930     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.12.2039     Document Type: Article

References (50)

1. Hormones and mammary carcinogenesis in mice, rats and humans: A unifying hypothesis
2. The mammary gland: A unique organ for the study of development and tumorigenesis
3. Mechanisms of response and resistance to endocrine therapy for breast cancer and development of new treatments
4. Influence of pregnancy and lactation on experimental mammary carcinogenesis
5. Relationship between previous reproductive history and chemically induced mammary cancer in rats
6. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas
7. Changes in estrogen receptor, progesterone receptor and pS2 expression in tamoxifen-resistant human breast cancer
8. Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications
9. Epidermal growth factor in NMU-induced mammary tumors in rats
10. Use of aromatase inhibitors in breast carcinoma
11. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells
12. A hypersensitive estrogen receptor-α mutation in premalignant breast lesions
13. Cross-talk between peptide growth factor and estrogen receptor signaling pathways
14. A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue
15. Developmental regulation of the rat insulin-like growth factor I receptor gene
16. The meu oncogene encodes an epidermal growth factor receptor-related protein
17. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
18. Mosaic evolution of the insulin-like growth factors. Organization, sequence and expression of the rat insulin-like growth factor I gene
19. Isolation of a full-length cDNA encoding mouse aromatase P450
20. Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse
21. Structural organization and expression of the mouse estrogen receptor
22. Refractoriness to mammary tumorigenesis in parous rats: Is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?
23. Lactogenic response of cultured mouse mammary epithelial cells to mouse placental lactogen
24. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
25. Measurement of endogenous subcellular concentration of steroids in tissue
26. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
27. Crosstalk between the insulin-like growth factors and estrogens in breast cancer
28. EGF-related peptides and their receptors in mammary gland development
29. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands
30. EGF-related peptides in the pathophysiology of the mammary gland
31. Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors
32. Function of the IGF-I receptor in breast cancer
33. Signal transduction via the MAP kinases: Proceed at your own RSK
34. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses
35. EGF receptor
36. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts
37. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells
38. Hyperexpression of mitogen-activated protein kinase in human breast cancer
39. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
40. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
41. Cyclin D1 in breast cancer
42. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression
43. Cyclin D1 expression is regulated by the retinoblastoma protein
44. The retinoblastoma protein and cell cycle control
45. The clonal evolution of tumor cell populations
46. Differentiation of malignant to benign cells
47. Tumor heterogeneity
48. Characterization of insulin-like growth factor 1 receptors (IGF-IR) in human breast cancer cell lines
49. Insulin and insulin-like growth factor signaling are defective in MDA-MB-468 human breast cancer cell line